Hangzhou AGS MedTech Co. Ltd. A (688581) — Cash Flow Reinvestment Rate
Hangzhou AGS MedTech Co. Ltd. A (688581) has a Cash Flow Reinvestment Rate of 0.42x as of December 2025, reinvesting CN¥63.47 Million (capex CN¥63.47 Million ) from operating cash flow of CN¥151.20 Million. Explore 688581 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hangzhou AGS MedTech Co. Ltd. A Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for Hangzhou AGS MedTech Co. Ltd. A across 5 annual periods. Also explore how large is Hangzhou AGS MedTech Co. Ltd. A's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hangzhou AGS MedTech Co. Ltd. A (2021–2025)
Year-by-year capital reinvestment analysis for Hangzhou AGS MedTech Co. Ltd. A. For live market cap and broader valuation context, see Hangzhou AGS MedTech Co. Ltd. A market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | CN¥63.47 Million | CN¥151.20 Million | CN¥63.47 Million | ▲ +167.2% |
| 2024 | 0.16x | CN¥49.60 Million | CN¥315.80 Million | CN¥49.60 Million | ▼ -32.6% |
| 2023 | 0.23x | CN¥51.57 Million | CN¥221.45 Million | CN¥51.57 Million | ▼ -39.4% |
| 2022 | 0.38x | CN¥60.12 Million | CN¥156.38 Million | CN¥60.12 Million | ▲ +179.0% |
| 2021 | 0.14x | CN¥16.29 Million | CN¥118.25 Million | CN¥15.66 Million | — |